|
시장보고서
상품코드
1819976
수술용 현미경 시장 보고서 : 유형, 용도, 최종 용도, 지역별(2025-2033년)Surgical Microscopes Market Report by Type, Application, End Use, and Region 2025-2033 |
||||||
세계 수술용 현미경 시장 규모는 2024년 15억 달러에 달했습니다. IMARC Group은 이 시장이 2033년까지 35억 달러에 달하고, 2025-2033년 9.16%의 연평균 성장률(CAGR)을 보일 것으로 예측했습니다. 3D 이미징, 로봇 공학 등 기술 발전, 최소침습 수술에 대한 수요 증가, 만성 질환에 취약한 인구의 고령화, 신경외과, 안과 등 복잡한 수술의 정확도 향상, 환자 결과 개선 및 회복 속도 향상 등이 시장 성장을 가속하는 주요 요인으로 꼽힙니다.
획기적인 기술 발전
이미지 처리, 확대 및 정밀 기술의 지속적인 개선으로 수술용 현미경은 더욱 효과적이고 사용자 친화적입니다. 3D 시각화, 형광 이미징, 로봇 공학의 통합과 같은 기술 혁신은 특히 신경외과나 안과와 같은 복잡한 수술의 정확도를 높이고 있습니다. 예를 들어, 2024년 자이스는 ZEISS SMILE과 ZEISS SMILE pro를 통해 1,000만 개 이상의 눈을 치료하여 굴절교정 산업의 세계 모멘텀을 확대했습니다. 자이스는 ZEISS SMILE pro-technology를 사용하여 수정체낭 추출을 통한 최초의 원시 치료를 발표했습니다. ZEISS ARTEVO 750과 ZEISS ARTEVO 850을 통해 자이스는 첨단 광학 현미경 및 디지털 안과용 현미경 포트폴리오를 CE 시장에 선보였습니다. 자이스는 AT ELANA 841P 삼중초점 인공수정체와 혁신적인 자이스 삼중초점 기술을 통한 새로운 임상 결과를 포함한 자이스의 첨단 인공수정체 포트폴리오를 전시하여 우수한 시력 결과를 강조하였습니다. 자이스는 자이스 AI IOL Calculator의 CE 마크를 획득하여 유럽 백내장 시장에 데이터 기반 인공수정체 도수 계산을 제공합니다. ZEISS CIRRUS PathFinder는 백내장 환자의 수술 전, 수술 후 자동 OCT 평가를 통한 완전 통합 AI 의사결정 지원을 제공한다(CE 마크 출원 중).
최소침습 수술에 대한 수요 증가
최소 침습 수술에 대한 선호도가 높아지면서 수술용 현미경에 대한 수요가 증가하고 있습니다. 이러한 현미경은 외과 의사가 복잡한 수술을 보다 정확하게 수행할 수 있게 하고, 회복 시간 단축, 합병증 감소, 환자 결과 개선으로 이어지기 때문에 수술용 현미경 시장 전망은 밝습니다. 예를 들어, 2024년 7월 인도 Kauvery Institute of Neurosciences의 의료진은 매우 복잡하고 정밀한 안와상 개두술을 시행했습니다. 수술팀은 고해상도 현미경 안내와 수술 중 신경생리학적 모니터링을 통해 뇌의 복잡한 해부학적 구조를 타의 추종을 불허하는 정확도로 탐색할 수 있었습니다. 이러한 첨단 기술을 통해 열쇠구멍 수술은 최대한의 정밀도로 수행되어 건강한 조직과 중요한 뇌 구조에 손상을 입힐 위험을 줄일 수 있었습니다. 이러한 장점은 최소침습 수술에 대한 선호도를 높이고 수술용 현미경 시장의 성장에 기여하고 있습니다.
만성질환 증가
암, 심혈관 질환, 신경퇴행성 질환 등 만성질환의 전 세계적인 증가와 고령화로 인해 외과적 개입에 대한 수요가 증가하고 있습니다. 특히 신경외과, 이비인후과, 안과에서 수술용 현미경은 진단과 치료에 중요한 역할을 하며 수술용 현미경 시장의 성장을 주도하고 있습니다. 예를 들어, 2024년 4월 Northwestern Medicine에서 발표한 논문에 따르면, 세계보건기구(WHO)는 주로 운동신경세포의 기능장애와 상실을 특징으로 하는 신경퇴행성 질환을 앓고 있는 사람이 전 세계적으로 5,000만 명에 달할 것으로 추정하고 있으며, 이 숫자는 인구의 고령화에 따라 증가할 것으로 예상하고 있습니다. 증가할 것으로 예상되고 있습니다. 2023년 미국에서 약 670만 명이 발병할 것으로 예상되는 알츠하이머병은 뇌세포가 크게 손실되는 질환입니다. 마찬가지로 미국심장협회가 2024년 1월에 발표한 논문에 따르면, 심장병은 100년 이상 미국 내 주요 사망 원인으로 꼽힙니다. 이러한 통계는 전 세계적으로 만성 질환의 유병률이 증가하고 있으며, 이는 수술용 현미경의 필요성을 촉진하고 시장 성장에 기여하고 있습니다.
The global surgical microscopes market size reached USD 1.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.16% during 2025-2033. Technological advancements like 3D imaging and robotics, the rising demand for minimally invasive surgeries, an aging population base susceptible to chronic diseases, enhanced precision in complex procedures such as neurosurgery and ophthalmology, and improved patient outcomes and faster recovery are some of the major factors propelling the market growth.
Significant Technological Advancements
Continuous improvements in imaging, magnification, and precision technology have made surgical microscopes more effective and user-friendly. Innovations like 3D visualization, fluorescence imaging, and robotics integration enhance surgical accuracy, particularly in complex procedures like neurosurgery and ophthalmology. For instance, in 2024, ZEISS extended its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announced the first treatment for hyperopia with lenticular extraction using ZEISS SMILE pro-technology. The expanded portfolio of advanced optical and digital ophthalmic microscopes was introduced in CE markets with ZEISS ARTEVO 750 and ZEISS ARTEVO 850. ZEISS showcased its advanced ZEISS IOL portfolio, including new clinical results with the AT ELANA 841P trifocal IOL and its innovative ZEISS trifocal technology, highlighting excellent visual outcomes. ZEISS brings data-driven IOL power calculations to European cataract market with CE mark for the ZEISS AI IOL Calculator; ZEISS CIRRUS PathFinder provides fully integrated AI decision support through automated OCT assessment for pre-operative cataract patients (pending CE mark); ZEISS Surgery Optimizer features AI-based video segmentation to review, analyze, and share surgery videos post-surgery.
Rising Demand for Minimally Invasive Surgeries
The growing preference for minimally invasive surgeries facilitates the demand for surgical microscopes. These microscopes enable surgeons to perform intricate procedures with greater precision, which leads to faster recovery times, fewer complications, and better patient outcomes, thus creating a positive surgical microscopes market outlook. For instance, in July 2024, the medical team at Kauvery Institute of Neurosciences in India performed a highly intricate and precision-driven Supraorbital Craniotomy, a minimally invasive procedure with a keyhole approach involving a small incision along the eyebrow, to delicately remove the tumor. Under high-resolution microscopic guidance and intraoperative neurophysiological monitoring, the surgical team was able to navigate the intricate anatomy of the brain with unparalleled precision. These advanced techniques ensured the keyhole surgery was performed with maximum accuracy, reducing the risk of damage to healthy tissues and critical brain structures. These associated advantages facilitate the preference for minimally invasive procedures, thereby contributing to the market growth of surgical microscopes.
Increasing Prevalence of Chronic Diseases
The global rise in chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative diseases, along with the aging population, is creating a higher demand for surgical interventions. This is particularly relevant in neurosurgery, ENT, and ophthalmology, where surgical microscopes play a crucial role in diagnostics and treatments, thereby driving the surgical microscopes market growth. For instance, as per an article published by Northwestern Medicine in April 2024, the World Health Organization estimates that 50 million people worldwide are affected by neurodegenerative disorders - primarily characterized by motor neuron dysfunction and loss - and that number is expected to rise as the population ages. Alzheimer's disease, which is expected to affect about 6.7 million patients in the U.S. in 2023, results in a substantial loss of brain cells. Similarly, according to an article published by the American Heart Association in January 2024, heart disease has been the primary killer for more than a century in the United States. These statistics are reflective of the increasing prevalence of chronic diseases across the globe, which is facilitating the need for surgical microscopes, thereby contributing to the market growth.
On casters accounts for the majority of the market share
Surgical microscopes on casters dominate the market due to their mobility, flexibility, and ease of use in diverse surgical settings. These microscopes can be easily moved across operating rooms, allowing surgeons to adjust their position during procedures without disrupting workflow. Their portability makes them ideal for hospitals and outpatient clinics that require versatile equipment for various surgeries. Additionally, on-caster microscopes are cost-effective, providing high functionality without the need for permanent installations, making them a practical choice for healthcare facilities.
Ophthalmology holds the largest share of the industry
Ophthalmology accounts for the major segment in the market due to the high precision required in eye surgeries, such as cataracts, glaucoma, and retinal procedures. These microscopes provide enhanced visualization, magnification, and illumination, which are crucial for delicate ophthalmic surgeries. The increasing prevalence of eye disorders, particularly among the aging population, drives the demand for advanced surgical tools. Additionally, frequent technological advancements in ophthalmic surgery techniques further boost the adoption of surgical microscopes in this specialty.
Hospitals represents the leading market segment
Hospitals hold the largest share of the market due to their extensive infrastructure and ability to invest in advanced medical technologies. They perform a wide range of complex surgeries, requiring high-precision equipment like surgical microscopes. Hospitals also cater to a large patient base, particularly for specialized procedures such as neurosurgery, ophthalmology, and ENT surgeries. Moreover, the availability of skilled surgeons and integrated healthcare services further supports the adoption of surgical microscopes, making hospitals key players in the market.
North America leads the market, accounting for the largest surgical microscopes market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical microscopes.
Advanced healthcare infrastructure and high investment in cutting-edge medical technologies are driving the market growth across the North American region. The region's increasing demand for minimally invasive surgeries, particularly in fields like neurosurgery, ophthalmology, and ENT, boosts market growth. Additionally, the rising prevalence of chronic conditions such as cancer and cardiovascular diseases necessitates precision surgeries, driving the adoption of surgical microscopes. Technological advancements, such as robotics and AI integration in surgical tools, also fuel the demand across North America. For instance, in January 2023, Leica Microsystems, a technology leader in microscope and image analysis solutions, announced that it has entered into a distribution agreement with DB Surgical, Inc. that includes the expansion territories of North Carolina and South Carolina. Under the agreement, DB Surgical, Inc. will function as the exclusive sales and service provider for Leica's medical portfolio in Alabama, Florida, and Georgia as well as in North Carolina and South Carolina.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)